MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03305nam a22002777a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
MED 2013 0008 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
PILC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240720152609.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
160505b2013 xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Language of cataloging |
eng |
| Transcribing agency |
FEU-NRMF MEDICAL LIBRARY |
| Description conventions |
rda |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
english |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
MED 2013 0008 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Comparison of the predictive value of CHADS2 and CHA2DS2 VASc among Filipino patients with coronary artery disease without atrial fibrillation for ischemic stroke admitted at FEU-NRMF from 2009-2012 |
| Remainder of title |
a case control study / |
| Statement of responsibility, etc. |
Ramil Y. Macapagal, Greg V. Dayrit and Ramon Pineda. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Fairview, Quezon City: |
| Name of publisher, distributor, etc. |
Department of Internal Medicine, FEU-NRMF, |
| Date of publication, distribution, etc. |
2013. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Other physical details |
illustrations, tables; |
| Dimensions |
(in folder) |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Abstract: The CHADS2 score and other similar risk stratification schemes have proven useful in populations with known Atrial Fibrillation, the vast majority (85%) of ischemic occur in individuals without known Atrial Fibrillation. Patients with coronary heart disease (CHD) are at increased risk for stroke, and each of the component comorbidities of the CHADS2 score has been independently associated with stroke in large cohorts of patients with Coronary Heart Disease. CHA2DS2-VASc a new scoring system for risk stratification among atrial fibrillation for ischemic stroke is the modification of CHADS2 score. The study evaluates the CHADS score and CHA2DS2-VASc score for prediction of ischemic stroke/TIA among Filipino patients with Coronary Heart Disease without Atrial Fibrillation at FEU-NRMF. This is a Case Control Study. All Filipino patients with Coronary Artery Disease without Atrial Fibrillation with Ischemic Stoke (Case) or without Ischemic stroke (Control) were studied. CHADS2 (congestive heart failure (CHF), Hypertension, age≥ 75, diabetes (1 point each), and prior stoke or transient ischemic attack (TIA) (2 points) and the CHA2DS2-VASc (CHA2DS2-Vascular disease, Age 65-74 years, Sex category) (1 point each) score were calculated. A total of 752 subjects were studied, among them 188 subjects have ischemic stroke. In comparison of CHADS2 and CHAD2DS2-Vasc scoring between cases and controls, the results showed that there was a significant difference noted as proven by the p values 0.001 and 0.008 respectively. The CHAD2DS2-Vasc scoring of cases were significantly higher than controls. The CHADS2 risk score and the CHAD2DS2-Vasc risk score have a significant predictive value for Ischemic Stroke/TIA among patients with Coronary Artery Disease without Fibrillation. Also, CHAD2DS2-Vasc risk score comparing CHADS2 risk score due to its additional non-major stroke risk factors may be better in discriminating between patients at a low and high risk of stoke. The 2 scoring system may also have role in identification of high-risk individuals who may benefit from stroke prevention therapies or screening for silent atrial fibrillation. |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
Research - Department of Medicine |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Macapagal, Ramil Y., MD. |
| Relator term |
principal investigator |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Dayrit, Greg V., MD. |
| Relator term |
supervising investigator |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Pineda, Ramon, MD. |
| Relator term |
supervising investigator |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Room Use |
